RecruitingNot Applicable

Hybrid Type I Effectiveness-Implementation Trial of a Social Network Support Intervention

United States900 participantsStarted 2023-02-13

Plain-language summary

The goal of this Hybrid Type I effectiveness-implementation trial is to test an evidence-based, flexible, and tailored intervention that leverages existing social network members to promote retention in care and viral suppression among people living with HIV aged 18-49.

Who can participate

Age range

18 Years – 49 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria for Index Participants: * Aged 18-49 years old, inclusive * Speak English * Own a cell phone not shared with anyone else * Have missed at least one HIV care scheduled visit or have not been virally suppressed in the past 24 months. * Resides in Chicagoland, Illinois or Alabama Exclusion Criteria for Index Men: * If a participant fails to meet all inclusion criteria Inclusion Criteria for Support Confidants: * Index agrees to engage the Support Confidant * Age 18 years or older * Speaks English * Owns a cell phone not shared with others * Is not a romantic/sexual partner of the Index participant Exclusion Criteria: * Romantic/Sexual partners of Index participant * Relationship strain or abuse present in Index-Support Confidant relationship

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Missed Visit Proportion

Timeframe: 18 months

Viral Suppression

Timeframe: 18 months

Trial details

NCT IDNCT05723653

SponsorUniversity of Chicago

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-12-31

Contact for this trial

Alida Bouris, PhD

773-834-4304 abouris@uchicago.edu

View on ClinicalTrials.gov More HIV Seropositivity trials

Who can participate

Age range

18 Years – 49 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.